14/09/2026 04:00
|
Medical, Health & Aged Care
NUCALA (mepolizumab) is now listed on the Pharmaceutical Benefits Scheme (PBS) for adults with uncontrolled COPD and raised blood eosinophils as an add-on to inhaler triple therapy. [1,2]In 2022,...